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Objective: Psychiatric advance directives (PADs) provide a
legal mechanism for competent adults to document care
preferences and authorize a surrogate to make treatment
decisions. In a controlled research setting, an evidence-based
intervention, the facilitated psychiatric advance directive
(FPAD), was previously shown to overcome most barriers to
PAD completion. This study examined implementation of the
FPAD intervention in usual care settings as delivered by peer
support specialists and nonpeer clinicians on assertive com-
munity treatment (ACT) teams.
Methods: A total of 145 ACT consumers were randomly
assigned, within teams, to FPAD with facilitation by either a
peer (N=71) or a clinician (N=74). Completion rates and
PAD quality were compared with the previous study’s
standard and across facilitator type. Logistic regression
was used to estimate effects on the likelihood of PAD
completion.
Results: The completion rate of 50% in the intent-to-treat
sample (N=145) was somewhat inferior to the prior standard
(61%), but the rate of 58% for the retained sample (those who
completed a follow-up interview, N=116) was not signifi-
cantly different from the standard. Rates for peers and cli-
nicians did not differ significantly from each other for either
sample. PAD quality was similar to that achieved in the prior
study. Four consumer variables predicted completion: in-
dependent living status, problematic substance use, length
of time served by the ACT team, and no perceived unmet
need for hospitalization in crisis.
Conclusions: Peers and clinicians can play a crucial role in
increasing the number of consumers with PADs, an impor-
tant step toward improving implementation of PADs in men-
tal health care.
Psychiatric Services in Advance (doi: 10.1176/appi.ps.201600423)
When a person with mental illness is in crisis and lacks ca-
pacity to give consent to treatment, he or she often must be
treated involuntarily, which can be distressing and may make
future voluntary care feel more coercive (1). Psychiatric ad-
vance directives (PADs) provide a legal mechanism for com-
petent adults with serious mental illness to document their
future crisis care preferences, consent to or refuse treatment
during a crisis, and authorize a trusted surrogate to make
treatment decisions for them during periods of decisional
incapacity. A PAD may consist of an advance instruction (AI)
for future health care, designation of a health care power of
attorney (HCPA), or both. PADs are designed to empower
people to direct their future treatment during times of crisis
and give consent to treatment, thus avoiding involuntary
treatment. Every state provides some legal mechanism for
advance treatment planning in the event of an incapacitating
mental health crisis; 26 states have enacted legislation spe-
cifically authorizing advance mental health care planning.
Previous research suggests very high consumer inter-
est in PADs, but studies have found low rates of actual
completion (2–4). PADs are challenging to complete
without assistance, and there are misunderstandings of
processes involved, concerns that directives may not be
followed, and feelings of uncertainty about directing future
decisions in unknown circumstances. Clinicians in routine
fee-for-service treatment encounters may be unable to devote
the time required to work with individuals to overcome these
barriers and to complete PADs. Other assistance is often
lacking.
An evidence-based intervention, the facilitated psychi-
atric advance directive (FPAD), was found to overcome
most barriers to PAD completion when it was delivered by
trained research associates in a controlled research setting
(5). Findings also suggested that PADs can serve as effective
recovery tools: PAD completion has been shown to yield
significant benefits to consumers, including fewer coercive
interventions (6), a better working alliance with care pro-
viders (4), and higher odds that individuals will receive
and adhere to their preferred medications (7). Yet imple-
mentation of PADs lags far behind consumer interest,
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despite provider requirements to implement PADs as a
condition of participation in Medicare and Medicaid (8),
dissemination of research findings via online resources
(http://www.nrc-pad.org), and awareness raising by advo-
cacy groups (9,10).
In this study, we implemented the FPAD intervention in
usual care settings as delivered by two kinds of community-
based staff on assertive community treatment (ACT) teams:
certified peer support specialists and nonpeer clinicians
(referred to below as peers and clinicians). People served
by ACT teams are high-priority candidates for PADs be-
cause they have serious mental illnesses (11) and are at high
risk of experiencing repeated crises and potential loss of
capacity to make health care decisions. PAD facilitation is
likewise well aligned with recovery-oriented ACT teams
and staff roles (12).
Successful implementation of FPAD by ACT team peers
or clinicians would create a pool of potential facilitators.
Peers and clinicians have different skill sets and work
responsibilities that could affect PAD facilitation rates
and quality. The peer’s role emphasizing empowerment
and recovery may be a natural fit with PAD facilitation,
because peers may be particularly able to help consumers
achieve some recovery outcomes (13,14), serve as role models
in recovery, and foster a person-centered process in suc-
cessful PAD completion. On the other hand, clinicians’
training may make it easier to formulate treatment prefer-
ences into clinically feasible and effective PADs. If PAD
facilitation can be conducted comparably well by a peer or
a clinician, it may be more advantageous to deploy peers
as PAD facilitators, given other clinical demands on clini-
cians (15).
The goal of this randomized controlled study was to
implement PAD facilitation in one type of usual care set-
ting and to compare the results for two different types of
facilitators: peers and clinicians. We asked the following
research questions: Is the rate of PAD completion in a
community mental health setting not inferior to the rate
established by research staff in the prior controlled ex-
perimental trial (4)? Is the rate of PAD completion dif-
ferent across peer versus clinician facilitators? Is the
quality of PAD documents completed in the usual care
setting not inferior to that of the prior trial? Does the qual-
ity of PADs differ between peer and clinician facilitators?
What baseline consumer characteristics predict completion
of a facilitated PAD?
METHODS
Sample Selection, Screening, Recruitment, and
Randomization
The sample consisted of 145 people with serious mental
illness receiving care from one of six ACT teams in cen-
tral North Carolina during 2013–2015. Study enrollment
criteria included current receipt of ACT services; age
18–70; chart diagnosis of schizophrenia, schizoaffective
disorder, bipolar disorder, other psychotic disorder, or
mood disorder with psychotic features; ability to give in-
formed consent to participate in a research study; not in
crisis, jail, or a hospital at the time of study enrollment;
likely ability to complete a research interview in English;
no existing PAD; and interest in learning more about
PADs.
Informed consent was obtained in person. Interviews av-
eraged 45 minutes, ranging from 30 to 60 minutes, and the
interviewer was blinded with regard to random assignment.
Respondents received $25 at completion of a baseline interview
and another $25 at completion of the follow-up interview. PAD
completion was not a requirement of participation. Selected
medical chart information was provided to the researchers by
the ACT team.
Each ACT team designated a peer and a clinician to re-
ceive training in PAD facilitation from the research team.
Consumers were randomly assigned, within teams, to facil-
itation from either a peer or a clinician. Facilitators were
given four months to complete PAD facilitation with each
randomly assigned consumer, but this time limit was ex-
tended during the study to accommodate facilitators and
consumers.
This study was approved by research ethics committees
at Duke University School of Medicine and entities associ-
ated with participating ACT teams.
Intervention and Training
The FPAD intervention is a manualized structured con-
versation to identify a person’s instructions for treatment
in advance of a future period of incapacity (5). The facil-
itators are trained to listen carefully and ensure that
the PAD document reflects the individual’s wishes. Peers
and other clinicians were trained by a doctoral-level psy-
chologist (LLM) according to procedures in the prior
study (4). Consumers who did not wish to complete
or notarize a PAD were still eligible for the follow-up
interview.
Measures
PAD completion. Tomeasure the rate of PAD completion, we
counted PADs that were completed, witnessed, and nota-
rized according to North Carolina law.
Descriptive and evaluative content analysis. A psychiatrist
(MSS), blinded to the random assignment, coded PADs to
categorize their structure (AI, HCPA, or both); information
content; and quality with regard to feasibility, consistency
with community standards, and usefulness and relevance of
the information provided, taking into account diagnosis,
local practice standards, and local health care resources.
Four domains were assessed: medication preferences;
hospital preferences; clinical information; and a summary
assessment of overall consistency, feasibility, and useful-
ness. A 4-point scale (for example, very consistent, mostly
consistent, somewhat inconsistent, and very inconsistent)
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was applied to the summary assessment and each of the
three domains. We dichotomized each of the four variables
for analysis (for example, 1, very or mostly consistent).
The same rating scale was used in prior PAD facilitation
research (4).
Other variables. From participants, we collected informa-
tion on age, gender, racial background, Latino ethnicity,
years of education, marital status, residential status, working
for pay in the last 6 months, problems associated with al-
cohol or substance use in last 30 days, arrest history, ACT
team utilization, involuntary treatment, and the percep-
tion of ever having needed hospitalization but not being
admitted. The baseline interview included the Insight and
Treatment Attitudes Questionnaire (ITAQ) (16) to assess
understanding of illness and the Colorado Symptom Index
(CSI) (17) to measure psychiatric symptomatology. Per-
ceived barriers to completing a PAD (for example, poor
understanding of PADs, lack of trust in doctors, and no
one to serve as a health care agent) were also evaluated
(18). From the medical record, we collected information
on diagnosis.
Statistical Analysis
The rate of PAD completion was calculated for two sam-
ples: the number of people assigned to facilitation at
baseline (the intent-to-treat [ITT] sample) and the num-
ber who completed a follow-up interview (the retained
sample). Unlike the ITT sample, by definition all indi-
viduals in the retained sample continued to be available
and eligible for the study during the study window; thus,
the retained sample was an arguably more stable subset
than the ITT sample. PAD completion rates were com-
pared with the previous study rate of 61% (4) by using
one-tailed chi-square tests to test for inferiority of the
community-delivered intervention to the prior standard,
a directional hypothesis. Two-tailed chi-square tests
were used to test the difference between facilitator types,
because there was no hypothesized direction of effect.
Comparisons of completion rates and quality were con-
ducted by using survey methods to account for cluster-
ing of facilitators and consumers into six ACT teams
(SAS PROC SURVEYFREQ using a Rao-Scott–modified
chi-square test).
To assess the results of randomization across the peer and
clinician study arms and the potential differences between
the ITT and retained samples, we compared demographic
and clinical variables by using chi-square tests for percent-
ages and t tests for means.
Logistic regression was used to model the likelihood
of PAD completion (either AI or HCPA), including vari-
ables such as facilitator assignment, demographic and clin-
ical characteristics, and treatment experience. Candidate
independent variables were tested in bivariate models and
selected for the multivariate model when p,.1. We used
survey methods to account for clustering by ACT team (SAS
PROC SURVEYLOGISTIC). SAS 9.4 or Excel was used for
all statistical procedures.
RESULTS
Screening and Enrollment
ACT staff reviewed records for 553 consumers on six ACT
teams during the study period, screened 357 for study eli-
gibility, and forwarded consent to contact for 190. A total of
145 eligible individuals gave consent to participate in the
study, completed baseline interviews, and were randomly
assigned to FPAD by either a peer (N=71) or a clinician
(N=74). Twenty-six became ineligible after randomization
(17 because they were no longer involved with the ACT
team), and three declined follow-up. The remaining 116 in-
dividuals (80% of those who enrolled in the study) com-
pleted a follow-up interview.
Sample Characteristics
Demographic, clinical, and attitudinal characteristics are
presented in Table 1. Random assignment of consumers to
peers and clinicians was successful, yielding peer and cli-
nician study arms with no statistically significant differences
between the ITT (N=145) and retained (N=116) samples on
any of the variables listed in Table 1 (results not shown). The
retained sample resembled the ITT sample on the listed
variables; however, individuals in the retained sample had
been with the ACT team twice as long as individuals in the
unretained sample (41.2 versus 20.2 months). Study par-
ticipants were clustered by ACT teams, which varied in
size and contributed a range of 14 to 36 study participants
each for the ITT sample and 11 to 30 each for the retained
sample.
Completion of PADs
All individuals who were randomly assigned to a peer or a
clinician and who remained eligible were approached about
meeting with a PAD facilitator. The mean length of time
between the baseline interview and declining or completing
the FPAD intervention was about five months (162670 days,
for N=127 reported by ACT teams; data missing for N=18).
The length of time between declining or completing the
intervention and participation in the follow-up interview
was 51635 days (N=116).
PAD completion rates were somewhat lower than the
61% rate achieved under controlled study conditions, but
the difference was statistically significant only for the ITT
sample, not for the retained sample. Of 145 individuals
who participated in the baseline survey (the ITT sample),
72 completed and notarized a PAD with their assigned
facilitators, for a completion rate of 50% (one-tailed test,
p=.030) (Table 2). Of 116 individuals who also completed
the follow-up interview (the retained sample), 67 com-
pleted and notarized a PAD with their assigned facilita-
tors, for a completion rate of 58% (a one-tailed test was not
significant). Separate comparisons of completion rates for
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each facilitator type and the 61% completion rate obtained
in the prior research study indicated no statistically sig-
nificant differences.
Completion rates for peers and clinicians were not sig-
nificantly different from each other, for either the ITT or
retained sample. In the ITT sample, completion rates were
42% for peers and 57% for clinicians (a two-tailed test was
not significant). In the retained sample, the completion rate
was 51% for peers and 63% for clinicians (a two-tailed test
was not significant).
ACT staff completed 72 PADs with consumers. Most (63%)
were stand-alone AIs, and the rest were joint AI and HCPA
documents. No stand-alone HCPAs were completed. ACT
teams varied in their rates of PAD completion (35%267%), in
TABLE 1. Characteristics of consumers served by assertive community treatment (ACT) teams, by intent-to-treat (ITT), retained, and
unretained samplesa
ITT (N=145) Retained (N=116) Unretained (N=29)
Test
Characteristic N % N % N % statisticb df
Demographic and socioeconomic
Age (M6SD) 41.9613.2 41.8612.8 42.2614.9 t=–.13 143
Gender x2=1.01 1
Female 62 43 52 45 10 34
Male 83 57 64 55 19 66
Race x2=.91 2
White 40 28 34 29 6 21
Black 97 67 76 66 21 72
Other 8 6 6 5 2 7
Latino ethnicity 3 2 1 1 2 7 x2=4.71 3
Education x2=3.41 2
,12 years 53 37 40 35 13 45
12–15 years 80 56 64 56 16 55
.15 years 11 8 11 10 0 —
Worked for pay in past 6 months 9 6 6 5 3 10 x2=1.07 1
Married or living with someone as
partner
27 19 23 20 4 14 x2=.56 1
Living in own home or apartment 67 46 56 48 11 38 x2=1.00 1
Homeless at least 1 night in past
6 months
23 16 15 13 8 28 x2=3.73 1
Ever arrested 92 63 73 63 19 66 x2=.07 1
Clinical and treatment history
Serious mental illness diagnosis x2=.73 2
Schizophrenia spectrum disorder 107 74 84 72 23 79
Bipolar disorder 29 20 24 21 5 17
Other 9 6 8 7 1 3
Any substance use disorder diagnosis
or problem (ever)
71 49 57 49 14 48 x2=.01 1
How often see people from ACT team x2=.93 1
Once a week or several times a
month
49 34 37 32 12 41
Once a day or several times a week 96 66 79 68 17 59
Total months served by ACT team
(M6SD)
37.0641.5 41.2644.3 20.2620.6 t=3.73* 98.2
Ever legally required to receive
treatment
34 23 28 24 6 21 x2=.15 1
Currently legally required to receive
treatment
7 5 7 6 0 — x2=1.84 1
Ever received involuntary treatment 130 90 104 90 26 90 x2=.00 1
Ever needed hospitalization but not
admitted
60 41 45 39 15 52 x2=1.60 1
ITAQ (M6SD)c 19.264.0 19.463.4 18.365.6 t=1.01 33.3
CSI (M6SD)d 54.0615.2 54.5614.6 52.1617.5 t=.78 143
Other
Perceived barriers to PAD (M6SD)e 3.462.4 3.662.4 2.762.3 t=1.81 143
a ITT, assigned to facilitation at baseline; retained, completed a follow-up interview; unretained, did not complete a follow-up interview
b For comparison of retained and unretained samples
c Insight and Treatment Attitudes Questionnaire. Possible scores range from 0 to 22, with higher scores indicating more insight.
d Colorado Symptom Index. Possible scores range from 5 to 75, with higher scores indicating fewer symptoms.
e Possible scores range from 0 to 9, with higher scores indicating more perceived barriers.
*p,.001
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the percentage of completed PADs that were facilitated by
peers as opposed to clinicians (25%267%), and in the percent-
age of completed PADs that included an HCPA (9%267%).
Quality of Completed PADs
PADs facilitated by ACT teams received quality ratings
similar to those in the prior research study. The percentage
rated as high quality (for example, mostly or very consistent)
ranged from 86% to 93% across four measures in this study,
similar to the range reported for the four measures in the prior
study (83%294%) (4). The percentage facilitated by peers and
rated as high quality ranged from 97% to 100%
across the four measures. The percentage fa-
cilitated by clinicians and rated as high quality
ranged from 76% to 90%. The quality of PADs
did not differ significantly between the two
facilitator groups.
Predictors of PAD Completion
Six of the baseline variables were associated
with completing a PAD (a p value of ,.1 was
used as a screen for inclusion in the mul-
tivariate model): having more education
(12 years or more), being married or part-
nered, living in one’s ownhome or apartment,
having a diagnosis of a substance use disor-
der or self-reported substance use problem, a
greater length of time being served by an ACT
team, and responding “no” to the question,
“Have you ever felt that you needed to go into
the hospital but were not admitted?” In mul-
tivariate analysis, four variables remained
significant (Table 3). The odds of completing
a PAD were more than two times greater for
participants who lived in their own home or
apartment compared with those with other
types of residential status, such as living in
a shelter or rooming house or with parents.
The odds of completing a PADwere also greater
(odds ratio=1.68) for those with a diagnosed substance use
disorder or a self-reported substance use problem compared
with those without such a diagnosis or problem. For par-
ticipants who answered “no” to the question about having an
unmet past need for hospitalization, the odds of completing a
PAD were more than two times greater than for those who
answered “yes” to that question.
DISCUSSION
This study of PADs implementation showed that PADs can
be facilitated, completed, and notarized in a community-
based mental health setting by both peers and clinicians
working on ACT teams. The quality of PADs was similar to
that achieved under controlled conditions in a prior study
(4). The PAD completion rate achieved in the ITT sample
was somewhat inferior to the rate in the prior study of 61%;
however, the rate for the arguably more stable retained
sample (those who completed the follow-up interview) was
not inferior to the rate in the prior study. The rates achieved
by peers and clinicians were not statistically different from
each other for the ITT and retained samples.
The modestly lower rate of PAD completion for the ITT
sample in this study compared with the rate in the prior
controlled research study is not unexpected given the more
clinically challenging ACT population. The most conser-
vative explanation for the somewhat inferior PAD com-
pletion rate in the ITT sample is the trend toward a lower
TABLE 2. Completion of psychiatric advance directives (PADs) by consumers
served by assertive community treatment (ACT) teams, by facilitator and samplea
ITT
(N=145)
Retained
(N=116)
Unretained
(N=29)
Facilitator and PAD type N % N % N %
ACT team (both facilitator types)
Type of PAD completedb
Stand-alone advance instruction 45 31 41 35 4 14
Both advance instruction and
health care power of attorney
27 19 26 22 1 3
Total with any PAD 72 50 67 58 5 17
Facilitator type
Peer support specialistc
Type of PAD completed
Stand-alone advance instruction 16 23 14 26 2 11
Both advance instruction and
health care power of attorney
14 20 13 25 1 6
Total with any PAD 30 42 27 51 3 17
Nonpeer cliniciand
Type of PAD completed
Stand-alone advance instruction 29 39 27 43 2 18
Both advance instruction and
health care power of attorney
13 18 13 21 0 —
Total with any PAD 42 57 40 63 2 18
a ITT, assigned to facilitation at baseline; retained, completed a follow-up interview; unretained,
did not complete a follow-up interview
b No consumer completed a stand-alone health care power of attorney.
c A total of 71 individuals were randomly assigned to receive the facilitated psychiatric advance
directive intervention via a peer, and 53 were retained.
d A total of 74 individuals were randomly assigned to receive the facilitated psychiatric advance
directive intervention via a clinician, and 63 were retained.
TABLE 3. Multivariate logistic regression model predicting
completion of psychiatric advance directives by 145 consumers
served by assertive community treatment (ACT) teamsa
Characteristic OR 95% CI p
Education: 12 years or more (reference:
,12)
1.50 .77–2.95 .237
Married or partnered (reference: no) 1.52 .69–3.36 .297
Lives in own home or apartment
(reference: no)
2.23 1.00–4.97 .049
Any substance use disorder diagnosis or
problem (ever) (reference: no)
1.68 1.05–2.69 .030
Time on ACT team (in months) 1.01 1.00–1.01 .016
No perceived unmet need for
hospitalization in crisis (reference:
perceived unmet need)
2.43 1.55–3.81 ,.001
a Survey methods were used to account for clustering of consumers in 6 ACT
teams.
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completion rate with the peer facilitators, compared with
the previous controlled study conditions (42% versus 61%).
Far fewer HCPA documents were created in this study
than in the prior study. Of the total number of PADs facili-
tated by research staff in the prior study, 71% (103 of 146)
were joint AI-HCPA documents and 8% (11 of 146) were
stand-alone HCPAs. In the study reported here, 38% (27 of
72) were joint AI-HCPA documents and there were no
stand-alone HCPAs completed. It is possible that more con-
sumers on ACT teams lacked trusted social contacts that
could serve as HCPAs, compared with the consumers in the
prior study, or that the continuous availability of the ACT
team made the HCPA function seem less compelling. It is
also possible that ACT facilitators felt less comfortable fa-
cilitating HCPA documents because such documents seemed
less clearly aligned with consumer self-determination, com-
pared with AI documents. Such barriers could be overcome
with additional training on the role and potential value of
assigning a HCPA—for example, as an advocate for wishes
expressed in the AI.
Individual characteristics at baseline associated with
PAD completion in multivariate analysis included living
in one’s own home or apartment and ACT team stability.
These characteristics suggest higher functioning; however,
scores on the ITAQ and CSI were not associated with PAD
completion. The finding of a higher PAD completion rate
among individuals with a diagnosis of a substance use dis-
order or a self-reported substance use problem is difficult to
interpret. One possibility is that persons in treatment for
substance use disorders have become more aware of their
risk of future relapse and decisional incapacity and the need
for a PAD. Compared with the group without substance use
disorders, the group with such disorders reported higher
rates of past arrest and unmet need for hospitalization,
suggesting that the experience of arrest rather than treat-
ment could motivate those with substance use disorders to
create PADs.
The limitations of this study included a small sample and
the distribution of individuals into six ACT team clusters,
reducing the ability to detect group-level differences be-
tween facilitator types across clusters. We did not study
the facilitation process, and this study had less rigorous
fidelity assessment than in the controlled trial. Never-
theless, high quality ratings of completed PAD documents
suggest that the intervention as delivered was faithful to
the model.
CONCLUSIONS
This research demonstrated that PAD facilitation can be
carried out by ACT team staff with individuals at high risk of
losing decisional capacity. Peers and clinicians facilitated
PAD completion at similar rates, and the rates compared
well to rates in prior research (4). PAD facilitation may be
considered as an expanded role for peer specialists in ACT
and other community mental health settings, offering an
additional workforce to complete PADs. For PADs to fulfill
their promise, there must be enough PADs in health care
settings so that providers implement them in mental health
care, just as they have come to do in advance medical care
planning. Peers and clinicians could play an important role
in increasing the supply of PADs to achieve this goal.
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